Bio Key International Inc (BKYI) Stock Price & Analysis

Bio Key International Inc (BKYI) fell 2.03% to USD 4.55 as of July 25, 2026 at 12:37 UTC, according to Nexqual real-time market data.

BKYI last closed at USD 4.64; the session ranged USD 4.48–4.64 on volume of 3,134 shares. Market capitalization is $4.93M, with a 52-week range of USD 3.1–19.7 (NCM). Source: Nexqual, July 25, 2026 at 12:37 UTC.

Key Statistics (as of July 25, 2026 at 12:37 UTC)

PriceUSD 4.55
Change▼ 2.03% (down)
Previous CloseUSD 4.64
OpenUSD 4.51
Day RangeUSD 4.48 – 4.64
52-Week RangeUSD 3.1 – 19.7
Volume3,134 shares
Market Cap$4.93M
ExchangeNCM

Technical Analysis (BKYI)

Nexqual's technical model rates BKYI "NEUTRAL" based on 3 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 12:37 UTC.

Overall SignalNEUTRAL
RSI (14)49.3 (neutral)
vs SMA50Above (USD 4.47)
MACD0.03 (positive)

Analyst Ratings (BKYI)

Wall Street analysts rate BKYI "Buy" based on 1 analysts, with a mean price target of USD 20 (range USD 20–20), per Nexqual as of July 25, 2026 at 12:37 UTC.

Consensus RatingBuy
Analyst Count1
Mean TargetUSD 20
High TargetUSD 20
Low TargetUSD 20
Buy / Hold / Sell1 / 0 / 0

Earnings (BKYI)

EPS EstimateUSD -0.82
Revenue Estimate$1.80M

Recent Earnings History

QuarterActual vs Estimate
2026-03-31USD -0.13 vs est -0.6 ▲ beat
2025-09-30USD -1.49 vs est -1.2 ▼ miss
2025-06-30USD -2 vs est -1.5 ▼ miss

Source: Nexqual, July 25, 2026 at 12:37 UTC.

Financials & Fundamentals (BKYI)

Total Revenue$6.48M
Revenue Growth (YoY)+33.50%
Gross Margin+77.30%
Operating Margin-7.35%
Profit Margin-102.32%
ROE-106.71%
Debt / Equity14.45
Current Ratio1.41
Total Cash$2.25M
Total Debt$706,695
Free Cash Flow$-2.48M

Source: Nexqual, July 25, 2026 at 12:37 UTC.

Financial Health Score (BKYI)

Nexqual rates Bio Key International Inc's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 12:37 UTC.

GrowthCritical — Revenue -100% YoY (annual), sharp decline
ProfitabilityWeak — Not yet profitable — scaling phase
Balance SheetStrong — $2M cash, no debt
Cash FlowWeak — Operating cash flow -$4M
EfficiencyCritical — ROE -107%, ROA -24.8%

Ownership (BKYI)

Insider Ownership+11.46%
Institutional Ownership+7.26%
Shares Outstanding1.09M
Float984,867
Short % of Float+0.13%

Source: Nexqual, July 25, 2026 at 12:37 UTC.

Leadership (BKYI)

Bio Key International Inc is led by Michael W. DePasquale (age 70), Chairman & CEO, per Nexqual as of July 25, 2026 at 12:37 UTC.

Chairman & CEOMichael W. DePasquale (age 70)
MD of Hong Kong & Vice-Chairman of the BoardKwok Fong Wong (age 62)
Chief Financial OfficerCecilia C. Welch (age 65)
Chief Technology OfficerMira K. LaCous (age 63)
Managing Director of AfricaAkintunde Carlton Jeje

Major Backers & Investors (BKYI)

Notable institutional backers of Bio Key International Inc include Citigroup Inc., Virtu Financial LLC, Susquehanna International Group, LLP, according to Nexqual as of July 25, 2026 at 12:37 UTC.

Active Investors

InvestorStake
Citigroup Inc.0.46%
Virtu Financial LLC0.19%
Susquehanna International Group, LLP0.16%

Index Funds (Passive)

FundStake
Geode Capital2.72%
Vanguard Group0.64%

Source: Nexqual, July 25, 2026 at 12:37 UTC.

From Bio Key International Inc's Latest SEC 10-K Filing (filed 2026-06-12)

Partnerships

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

SymbolNamePriceChange
OLOXOlenox Industries Inc.USD 5.18▼ 12.94%
BOXLBoxlight CorporationUSD 3.55▲ 3.5%
PHIOPhio Pharmaceuticals Corp.USD 1.04▼ 1.89%
SPCBSuperCom, Ltd.USD 10.71▼ 2.1%
WORXSCWorx Corp.USD 0.59▲ 3.33%

Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 12:37 UTC. This page is informational and not investment advice.